NCT06514378View on ClinicalTrials.gov

Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Chronic Lung DiseaseLung Transplant Rejection
Interventions
BIOLOGICAL

Mesenchymal stem cells

Endobronchial administration of 10⁶ MSCs/kg in each transplanted lung, 4 weeks apart.

Trial Locations (1)

Unknown

RECRUITING

Hospital Universitario Puerta de Hierro Majadahonda, Madrid

All Listed Sponsors
collaborator

Ministerio de Ciencia, Innovación y Universidades

UNKNOWN

lead

Instituto De Investigación Sanitaria Puerta De Hierro-Segovia De Arana

OTHER